Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes
| Tracking Information | |||
|---|---|---|---|
| First Submitted Date ICMJE | October 2, 2018 | ||
| First Posted Date ICMJE | October 4, 2018 | ||
| Last Update Posted Date | October 4, 2018 | ||
| Actual Study Start Date ICMJE | October 15, 2018 | ||
| Estimated Primary Completion Date | October 15, 2019 (Final data collection date for primary outcome measure) | ||
| Current Primary Outcome Measures ICMJE |
Participation Satisfaction with Continuous Glucose Monitoring[ Time Frame: 33 days after day 1 (visit 3 completion) ] This will be measured by the post intervention survey for How likely are you to recommend that a friend or family member with pre-diabetes wear a continuous glucose monitor (CGM). Participation Satisfaction with Continuous Glucose Monitoring[ Time Frame: 60 days (30 days after visit 3 completion) ] Qualitative themes related to participant satisfaction with CGM coded form post intervention interview. |
||
| Original Primary Outcome Measures ICMJE | Same as current | ||
| Current Secondary Outcome Measures ICMJE |
|
||
| Descriptive Information | |||
| Brief Title ICMJE | Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes |
||
| Official Title ICMJE | Continuous Glucose Monitoring With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes |
||
| Brief Summary | This study will recruit pre-diabetic patients to see if continuous glucose monitoring (CGM) with a low carbohydrate diet can reduce the percentage of time the CGM readings are above the normal range. Through this study it will demonstrate the feasibility of using CGM with a low carbohydrate diet to reduce weight and risk of developing diabetes in patients with pre-diabetes. Patients that appear to be eligible will be recruited from Michigan Medicine in the Family Medicine Clinic at the Livonia Center. |
||
| Detailed Description | |||
| Study Type ICMJE | Interventional | ||
| Study Phase | N/A | ||
| Study Design ICMJE | Allocation: Intervention Model: Single Group Assignment Intervention Model Description: Masking: Interventional Masking Description: Primary Purpose: Treatment |
||
| Condition ICMJE | |||
| Intervention ICMJE |
|
||
| Study Arms |
|
||
| Recruitment Information | |||
| Recruitment Status ICMJE | Not yet recruiting | ||
| Estimated Enrollment ICMJE |
15 | ||
| Original Estimated Enrollment ICMJE | Same as current | ||
| Estimated Study Completion Date | October 15, 2019 | ||
| Estimated Primary Completion Date | October 15, 2019 (Final data collection date for primary outcome measure) | ||
| Eligibility Criteria ICMJE | Inclusion Criteria: - A1C 5.7 to 6.4 (Most Resent A1C, not older than 1 year) - No diabetes medication including Metformin - BMI (body mass index) >30 - Must speak, read, adn write in English - No current pregnancy or breastfeeding - Must not classify as either Vegan or Vegetarian - Must be a patient at the Livonia Health Center Exclusion Criteria: - previous bariatric surgery | ||
| Sex/Gender |
|
||
| Ages | 21 Years and older (Adult, Older Adult) | ||
| Accepts Healthy Volunteers | No | ||
| Listed Location Countries ICMJE | United States | ||
| Removed Location Countries | |||
| Administrative Information | Has Data Monitoring Committee | No | |
| U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: Yes |
||
| IPD Sharing Statement |
|
||
| Responsible Party | Caroline Richardson,University of Michigan | ||
| Study Sponsor ICMJE | University of Michigan | ||
| Collaborators ICMJE | |||
| Investigators ICMJE |
|
||
| PRS Account | University of Michigan | ||
| Verification Date | October 2018 | ||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||

